Visa fourth-quarter profit jumps 33 percent

(Reuters) - Visa Inc's quarterly profit surged 33 percent as the payments network processed more transactions, led by higher consumer spending and a strengthening U.S. economy. Visa said on Wednesday total payments volumes jumped 11 percent, while the number of processed transactions rose 12 percent

Reuters October 25, 2018 03:05:13 IST
Visa fourth-quarter profit jumps 33 percent

Visa fourthquarter profit jumps 33 percent

(Reuters) - Visa Inc's quarterly profit surged 33 percent as the payments network processed more transactions, led by higher consumer spending and a strengthening U.S. economy.

Visa said on Wednesday total payments volumes jumped 11 percent, while the number of processed transactions rose 12 percent.

Net income rose to $2.85 billion or $1.23 per Class A share in the fourth quarter ended Sept. 30, from $2.14 billion or 90 cents per Class A share a year earlier. (http://bit.ly/2AqtikU)

(Reporting by Diptendu Lahiri in Bengaluru; Editing by Sai Sachin Ravikumar)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Cargo from Dubai arrives in Haifa, cementing Israel-UAE trade route
Business

Cargo from Dubai arrives in Haifa, cementing Israel-UAE trade route

By Rami Amichay HAIFA, Israel (Reuters) - The ship-to-shore crane paused above the cargo ship just arrived from Dubai, then set its load down on the pier in Israel.

As globe gallops into vaccine trials, insurers remain unfazed
Business

As globe gallops into vaccine trials, insurers remain unfazed

By Noor Zainab Hussain, Carolyn Cohn and Ludwig Burger LONDON/FRANKFURT (Reuters) - The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour. Yet, while more than 40 experimental COVID-19 vaccines are being tested on humans, the insurance companies with decades of experience in assessing the risks of clinical trials don't see anything to be unduly concerned about.

EU watchdog to clarify share trading after full Brexit
Business

EU watchdog to clarify share trading after full Brexit

By Huw Jones LONDON (Reuters) - The European Union's securities watchdog said it expects to make a statement soon on where shares listed in the bloc must be traded after Britain's full departure from the European Union in December.